tiprankstipranks
Advertisement
Advertisement

PSNL Stock Latest News

Personalis names Richard Chen president
The FlyPersonalis names Richard Chen president
7d ago
PSNL
Personalis’ NeXT Personal test shows predictive efficacy in breast cancer
PremiumThe Fly
Personalis’ NeXT Personal test shows predictive efficacy in breast cancer
12d ago
PSNL
Personalis price target lowered to $10 from $11 at Morgan Stanley
PremiumThe Fly
Personalis price target lowered to $10 from $11 at Morgan Stanley
19d ago
PSNL
Personalis: Strong MRD Growth Prospects Offset by Weak 2026 Outlook and Margin Pressure, Justifying Hold Rating
PremiumRatings
Personalis: Strong MRD Growth Prospects Offset by Weak 2026 Outlook and Margin Pressure, Justifying Hold Rating
19d ago
PSNL
Personalis Bets on Scale Despite Near-Term Losses
PremiumCompany Announcements
Personalis Bets on Scale Despite Near-Term Losses
24d ago
PSNL
Accelerated MRD Expansion Positions Personalis for Long‑Term Growth Despite Near‑Term Margin Pressure
PremiumRatingsAccelerated MRD Expansion Positions Personalis for Long‑Term Growth Despite Near‑Term Margin Pressure
25d ago
PSNL
Accelerating MRD Momentum and Reimbursement Tailwinds Support Buy Rating on Personalis
Premium
Ratings
Accelerating MRD Momentum and Reimbursement Tailwinds Support Buy Rating on Personalis
25d ago
PSNL
Personalis sees FY26 revenue $78M-$80M, consensus $81.7M
Premium
The Fly
Personalis sees FY26 revenue $78M-$80M, consensus $81.7M
26d ago
PSNL
Personalis reports Q4 EPS (26c), consensus (28c)
PremiumThe Fly
Personalis reports Q4 EPS (26c), consensus (28c)
26d ago
PSNL
Expanding Reimbursement and Market Reach Underpin Buy Rating and $13 Target on Personalis
PremiumRatings
Expanding Reimbursement and Market Reach Underpin Buy Rating and $13 Target on Personalis
1M ago
PSNL
Personalis’ MRD test receives Medicare coverage in lung cancer surveillance
PremiumThe Fly
Personalis’ MRD test receives Medicare coverage in lung cancer surveillance
1M ago
PSNL
Personalis announces publication of new study on NeXT Personal
PremiumThe Fly
Personalis announces publication of new study on NeXT Personal
2M ago
PSNL
Personalis price target raised to $13 from $12 at Guggenheim
PremiumThe FlyPersonalis price target raised to $13 from $12 at Guggenheim
2M ago
PSNL
Cathie Wood Doubles Down on High-Potential Biotech Plays
Premium
Market News
Cathie Wood Doubles Down on High-Potential Biotech Plays
2M ago
TER
TXG
NTLA, PSNL, KMTUY, ILMN: Cathie Wood Buys Early Biotech Stocks, Cuts Stakes in Illumina
Premium
Market News
NTLA, PSNL, KMTUY, ILMN: Cathie Wood Buys Early Biotech Stocks, Cuts Stakes in Illumina
2M ago
ILMN
NTLA
Personalis: Strengthened Balance Sheet and NeXT Personal Growth Underpin Reiterated Buy Rating and $12 Target
PremiumRatings
Personalis: Strengthened Balance Sheet and NeXT Personal Growth Underpin Reiterated Buy Rating and $12 Target
2M ago
PSNL
Accelerating Clinical Adoption and Expanding Medicare Reimbursement Support Buy Rating and Favorable Risk-Reward Profile
PremiumRatings
Accelerating Clinical Adoption and Expanding Medicare Reimbursement Support Buy Rating and Favorable Risk-Reward Profile
2M ago
PSNL
Personalis sees FY25 revenue $69M-$70M, consensus $69.96M
PremiumThe Fly
Personalis sees FY25 revenue $69M-$70M, consensus $69.96M
2M ago
PSNL
Personalis narrows Q4 revenue view to $17M-$18M from $15.7M-$20.7M
PremiumThe Fly
Personalis narrows Q4 revenue view to $17M-$18M from $15.7M-$20.7M
2M ago
PSNL
TEM, KDK, PSNL: Cathie Wood Loads Up on AI Health Tech, Trims SHOP & ROKU
PremiumMarket NewsTEM, KDK, PSNL: Cathie Wood Loads Up on AI Health Tech, Trims SHOP & ROKU
3M ago
GH
KDK
Personalis assumed with an Equal Weight at Morgan Stanley
Premium
The Fly
Personalis assumed with an Equal Weight at Morgan Stanley
4M ago
PSNL
Personalis Announces $100M Stock Offering Amendment
Premium
Company Announcements
Personalis Announces $100M Stock Offering Amendment
4M ago
8K
PSNL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >